Bicnu
NDC Package 0015-3012-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bicnu is a medication used to treat certain types of cancer (including multiple myeloma, brain tumor, Hodgkin's disease, non-Hodgkin's lymphoma). Marketed by E.r. Squibb & Sons, L.l.c., this product is identified by NDC 0015-3012 and is authorized under FDA application NDA017422.

Identification & Billing

NDC Package Code
0015-3012-60
Package Description
1 KIT in 1 CARTON * 30 mL in 1 VIAL, SINGLE-DOSE * 3 mL in 1 AMPULE
Product Code
0015-3012
11-Digit Billing Format
00015301260
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.

Clinical Specifications

Proprietary Name
Bicnu
Dosage Form
-
Usage Information
This medication is used to treat certain types of cancer (including multiple myeloma, brain tumor, Hodgkin's disease, non-Hodgkin's lymphoma). Carmustine belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
E.r. Squibb & Sons, L.l.c.
FDA Application #
NDA017422
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2009
End Marketing Date
09-30-2015
Listing Expiration
09-30-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0015-3012-60 identifies a specific commercial package of 1 kit in 1 carton * 30 ml in 1 vial, single-dose * 3 ml in 1 ampule of Bicnu, labeled by E.r. Squibb & Sons, L.l.c.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by E.r. Squibb & Sons, L.l.c. on June 01, 2009. The current certification is valid through September 30, 2015.

What are the primary indications for this medication?

This medication is used to treat certain types of cancer (including multiple myeloma, brain tumor, Hodgkin's disease, non-Hodgkin's lymphoma). Carmustine belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells.

How is this E.r. Squibb & Sons, L.l.c. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00015301260. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0015-3012-60
11-Digit CMS (5-4-2)
00015-3012-60

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.